Can a Patient's own blood help heal deep gum pockets?
NCT ID NCT07794046
First seen Aug 31, 2026 · Last updated Sep 01, 2026 · Updated 1 time
Summary
This trial tests whether adding a gel made from a patient's own blood, called albumin platelet-rich fibrin (Alb-PRF), to standard nonsurgical gum treatment improves healing of deep gum pockets in adults with periodontitis. Each participant has matched gum sites randomly assigned to receive either standard cleaning alone or standard cleaning plus the Alb-PRF gel. Researchers measure pocket depth and gum attachment at several time points over six months, and also check for changes in bacteria linked to gum disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Albumin platelet-rich fibrin (Alb-PRF), a material made from the participant's own blood, applied into gum pockets alongside standard nonsurgical periodontal therapy.
- What this could lead to
- If it works, adding Alb-PRF to standard gum cleaning could improve healing of deep gum pockets and help control the bacteria that drive periodontitis.
- What could go wrong
- This is a small early-stage trial with 24 participants, so results may not apply broadly. The added benefit of Alb-PRF over standard therapy alone remains uncertain, and the procedure carries typical risks like infection or discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 24 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 to 65 years. * Diagnosis of periodontitis according to the 2017 classification of periodontal and peri-implant diseases and conditions. * Presence of at least two clinically comparable periodontal sites within the same mouth that are suitable for a split-mouth design. * Periodontal probing depth of 5 mm or greater at the sites selected for randomization. * No systemic condition that would contraindicate nonsurgical periodontal therapy or adversely affect periodontal healing. * No current use of medications known to affect periodontal tissue healing. * No periodontal surgical treatment within the previous 6 months. * Ability to understand the study procedures, provide written informed consent, and attend the scheduled follow-up visits. Exclusion Criteria: * Current smoking or smoking cessation within the previous 6 months. * Diabetes mellitus, uncontrolled hypertension, serious cardiovascular disease, autoimmune disease, liver failure, kidney failure, or another systemic condition that may adversely affect periodontal healing or treatment. * Use of antibiotics, corticosteroids, bisphosphonates, antiresorptive agents, immunosuppressive agents, or other medications known to affect periodontal healing within the previous 6 months. * Pregnancy or lactation. * Acute periodontal abscess or acute endodontic infection at a selected study site. * Hematologic disease, bleeding disorder, anticoagulant therapy, or another condition that may interfere with venous blood collection. * Known hypersensitivity to any material used in the study. * Inadequate oral hygiene or inability to meet the oral hygiene requirements of the study protocol. * Current orthodontic treatment. * Inability or unwillingness to attend the scheduled follow-up visits.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Periodontitis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Gazi University Faculty of Dentistry, Department of Periodontology
Ankara, Ankara, 06490, Turkey (Türkiye)
-
Çankırı Karatekin University Faculty of Dentistry, Department of Periodontology
Çankırı, Çankırı, 18100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cost-Effectiveness and implementation of integrated Diabetes-Oral health care in oman: a health belief Model-Based intervention to enhance clinical, behavioral, and exploratory oral microbiome in health system outcomes in type 2 diabetes
- Can a Patient's own blood proteins help rebuild bone lost to gum disease?
- Can a gel help gums reattach to teeth after surgery?
- A deep-dive into gum disease: can a standard cleaning calm the body's tissue-damage signals?
- Can a seaweed extract help bones regrow in the jaw?
- Gum fluid proteins may hold clues to periodontal disease severity